Discovering that a medicine exists, is used elsewhere, and is not available to you is frustrating - especially when someone in the next county is taking it. There are four distinct filters between a medicine being invented and you being handed a box, and knowing which one is blocking you determines whether there is anything useful to do about it.
Filter one: the licence
The MHRA grants a marketing authorisation specifying which conditions, ages, doses and routes a medicine is approved for, based on the evidence the manufacturer submitted.
A medicine can be prescribed outside that - off-label - and commonly is, particularly in children and in palliative care. A medicine with no UK licence at all can be supplied as an unlicensed import.
So the licence is a filter rather than a wall, but it shifts responsibility onto the prescriber, which makes some reluctant.
See off-label and unlicensed prescribing and importing a medicine not available here.
Filter two: NICE
Being licensed does not mean the NHS pays for it.
NICE assesses whether a treatment represents good value, weighing benefit against cost.
Where NICE issues a technology appraisal recommending a treatment, the NHS is generally obliged to fund it within a set period - which is a genuine entitlement worth knowing about.
Where NICE has not recommended it, or has not assessed it, funding is not guaranteed.
NICE also produces clinical guidelines, which are recommendations rather than funding mandates.
Filter three: the local formulary
This is where most of the variation people notice comes from.
Local NHS organisations maintain a formulary - a list of preferred medicines - usually with a traffic-light system:
Green - suitable for a GP to prescribe routinely.
Amber - initiated by a specialist, then continued by the GP under a shared care agreement setting out who does the monitoring.
Red - hospital only, never prescribed in general practice.
Formularies differ between areas, which is the mechanism behind what gets called a postcode lottery. They exist to promote consistency and manage cost, and they are not arbitrary - but they do mean the answer can genuinely differ a few miles away.
Your GP cannot simply override a red or amber classification, which is worth understanding before pressing them.
Filter four: the prescriber
Finally, the clinician in front of you has to be satisfied it is appropriate for you, and takes personal responsibility for that decision.
Reasons for declining include interactions with what you already take, your kidney or liver function, pregnancy, a previous reaction, or a judgement that something else should be tried first.
A prescriber is also entitled to decline something they do not feel competent to monitor - which is a proper exercise of judgement rather than obstruction.
See when a prescription is refused and who can prescribe.
Finding out which filter applies
Ask directly, because the answer changes what to do next:
"Is this not licensed for my condition?" - then off-label prescribing may be possible with specialist support.
"Is it not funded here?" - then an individual funding request may be an option, or paying privately.
"Is it red or amber on the formulary?" - then a specialist referral is the route, not a repeat request to your GP.
"Is it unsuitable for me specifically?" - then the conversation is clinical rather than administrative.
That single question saves a great deal of frustration on both sides.
Individual funding requests
Where a treatment is not routinely commissioned, your clinician can apply for funding on the basis that your circumstances are exceptional - that you are likely to benefit significantly more than others with the same condition.
The request must come from the clinician, the bar is high, and there is an appeals process.
Simply having the condition does not meet the threshold, which is the point most applications founder on.
See paying for what the NHS will not fund.
Where private treatment fits
You can pay privately for something the NHS will not fund, and a private prescription can be dispensed at any pharmacy.
Two things to check before committing: who will monitor it, since a privately funded medicine still needs blood tests and reviews; and whether the NHS will later take over prescribing, which it may not.
Making the case
If you think a decision is wrong, the effective approach is clinical rather than adversarial.
Ask what would need to be true for the answer to change - which treatments must be tried first, which threshold must be met, which specialist opinion would carry weight.
Ask for a referral to someone who can initiate it if the issue is formulary classification.
Patient organisations for specific conditions frequently know these pathways well and can be genuinely useful.
Related reading: Prescriptions for Travel and Occupational Health, with more on prescriptions and pharmacy services in Prescriptions.